LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,496 | -28.3% | 6,300 | -13.7% | 0.00% | 0.0% |
| Q2 2023 | $526,330 | -2.0% | 7,300 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $536,988 | -80.3% | 7,300 | -82.1% | 0.00% | -77.8% |
| Q4 2022 | $2,723,102 | +715.3% | 40,765 | +951.7% | 0.01% | +800.0% |
| Q3 2022 | $334,000 | -81.3% | 3,876 | -80.6% | 0.00% | -83.3% |
| Q2 2022 | $1,783,000 | +113.8% | 19,979 | +270.0% | 0.01% | +200.0% |
| Q4 2021 | $834,000 | +10.9% | 5,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $752,000 | +6.2% | 5,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $708,000 | -26.0% | 5,400 | -14.0% | 0.00% | 0.0% |
| Q1 2021 | $957,000 | -72.0% | 6,276 | -81.7% | 0.00% | -80.0% |
| Q4 2020 | $3,412,000 | -9.8% | 34,313 | -13.5% | 0.01% | -23.1% |
| Q3 2020 | $3,783,000 | -58.1% | 39,689 | -50.8% | 0.01% | -71.1% |
| Q2 2020 | $9,022,000 | +22.9% | 80,660 | -20.1% | 0.04% | -25.0% |
| Q1 2020 | $7,339,000 | -59.2% | 100,928 | -41.4% | 0.06% | +11.1% |
| Q4 2019 | $17,970,000 | +78.3% | 172,305 | +70.1% | 0.05% | +58.8% |
| Q3 2019 | $10,081,000 | -58.3% | 101,278 | -52.2% | 0.03% | -58.0% |
| Q2 2019 | $24,184,000 | -28.4% | 211,863 | -21.2% | 0.08% | -26.4% |
| Q1 2019 | $33,779,000 | -10.5% | 268,705 | -3.4% | 0.11% | -25.7% |
| Q4 2018 | $37,756,000 | +55.9% | 278,233 | +215.4% | 0.15% | +124.2% |
| Q3 2018 | $24,211,000 | -1.7% | 88,202 | -25.8% | 0.07% | -9.6% |
| Q2 2018 | $24,626,000 | -0.2% | 118,867 | -20.4% | 0.07% | -11.0% |
| Q1 2018 | $24,679,000 | +207.8% | 149,423 | +153.7% | 0.08% | +192.9% |
| Q3 2017 | $8,019,000 | +178.2% | 58,899 | +148.1% | 0.03% | +180.0% |
| Q2 2017 | $2,882,000 | -77.9% | 23,742 | -78.2% | 0.01% | -82.1% |
| Q2 2016 | $13,016,000 | +298.8% | 109,129 | +258.1% | 0.06% | +250.0% |
| Q1 2016 | $3,264,000 | +50.8% | 30,475 | +52.6% | 0.02% | +60.0% |
| Q4 2015 | $2,164,000 | -51.4% | 19,964 | -54.8% | 0.01% | -52.4% |
| Q2 2015 | $4,452,000 | -32.7% | 44,125 | -48.6% | 0.02% | -36.4% |
| Q1 2015 | $6,615,000 | +159.3% | 85,793 | +78.9% | 0.03% | +135.7% |
| Q4 2014 | $2,551,000 | -23.3% | 47,944 | -32.3% | 0.01% | -6.7% |
| Q3 2014 | $3,327,000 | +75.3% | 70,801 | +132.4% | 0.02% | +66.7% |
| Q2 2014 | $1,898,000 | +19.9% | 30,464 | +29.4% | 0.01% | +12.5% |
| Q1 2014 | $1,583,000 | -17.5% | 23,535 | -46.9% | 0.01% | -33.3% |
| Q3 2013 | $1,918,000 | – | 44,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |